Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Nov 2020 for Greenwich LifeSciences, Inc., €9,101.
Filing timeline
BuySaleEric Rothe
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +524.5%Entry US$5.30 · Close at T+365 US$33.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Eric Rothe: trading record in brief
Our data holds just one disclosure by Eric Rothe, dated 24 November 2020, reporting an open-market purchase worth €9,101 in Greenwich LifeSciences, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Eric Rothe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 2,000 shares@ US$5.40100.0% of flowCommon StockSEC:0001493152-20-022374:0Canonical exit: 18 Feb 2021 (T+90)
1 of 1 declaration
